Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes.
Saved in:
| Title: | Sodium–glucose cotransporter 2 inhibition through henagliflozin ameliorates cognitive impairment in patients with type 2 diabetes. |
|---|---|
| Authors: | Zhang, Shujun1,2 (AUTHOR), Wang, Fen1,2 (AUTHOR), Xie, Lei1,2 (AUTHOR), Xu, Jialu1,2 (AUTHOR), Song, Xiaoqing1,2 (AUTHOR), Tao, Jing1,2 (AUTHOR), Chen, Juan3 (AUTHOR), Ma, Delin1,2 (AUTHOR), Yu, Xuefeng1,2 (AUTHOR), Shi, Xiaoli1,2 (AUTHOR), Yang, Yan1,2 (AUTHOR) yangyan6910@163.com |
| Source: | Journal of Diabetes Investigation. Nov2024, Vol. 15 Issue 11, p1596-1603. 8p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
